DEFR14A: CNS Pharmaceuticals Revises Reverse Stock Split Proposal, Opts for Cash Payments for Fractional Shares

CNS Pharmaceuticals has amended its reverse stock split proposal to provide cash payments instead of fractional shares to stockholders.

Summary

• CNS Pharmaceuticals is seeking stockholder approval for a reverse stock split with a ratio between 1-for-2 and 1-for-50.
• The company initially proposed issuing one full share for fractional shares resulting from the split, but has amended this to provide cash payments instead.
• The cash payment will be based on the closing price of the common stock on the effective date of the reverse stock split.
• The primary goal of the reverse stock split is to increase the per-share trading price to maintain NASDAQ listing compliance.
• The company received a delisting notice from NASDAQ due to its stock price falling below $1.00 per share.
• A hearing with a NASDAQ panel is scheduled for November 5, 2024, to appeal the delisting notice.
• The reverse stock split will not change the number of authorized shares of common or preferred stock, nor will it change the par value of the stock.
• The number of outstanding shares will be reduced, and the number of authorized but unissued shares will increase.
• The board has the discretion to implement the reverse stock split within one year of the special meeting and to determine the exact ratio.
• The company completed a 1-for-50 reverse stock split in June 2024, which temporarily increased the stock price but did not maintain the increase long-term.

Sentiment

Score: 4

Explanation: The document highlights the company's struggle to maintain its NASDAQ listing and the need for a reverse stock split, which is generally a sign of financial distress. While the company is taking steps to address the issue, the overall sentiment is negative due to the delisting notice and the failure of a previous reverse stock split to achieve long-term results.

Positives

• The reverse stock split is intended to increase the stock price, which could help maintain the company's NASDAQ listing.
• The company is addressing the issue of fractional shares by providing cash payments, which is a more straightforward approach for investors.
• The company is taking steps to appeal the delisting notice from NASDAQ.
• The reverse stock split will not change the terms of the common stock, including voting rights and rights to dividends.

Negatives

• The company's stock price has fallen below the NASDAQ minimum requirement, leading to a delisting notice.
• A previous reverse stock split in June 2024 did not result in a sustained increase in the stock price.
• The reverse stock split could be viewed negatively by some investors and may not result in a permanent increase in the stock price.
• The reverse stock split may result in some stockholders owning odd lots of shares, which can be more difficult to sell.
• There is no guarantee that the reverse stock split will attract institutional investors or improve trading liquidity.

Risks

• The reverse stock split may not result in a sustained increase in the stock price.
• The company could still be delisted from NASDAQ if it does not regain compliance with listing requirements.
• The increased number of authorized but unissued shares could have an anti-takeover effect and dilute existing shareholders.
• The company may need to raise additional capital in the future, which could further dilute shareholders.
• The market price of the common stock is dependent on many factors, including business and financial performance, general market conditions, and prospects for future success.

Future Outlook

The company aims to regain compliance with NASDAQ listing requirements through the reverse stock split and is seeking stockholder approval to proceed with the plan. The board has the discretion to implement the reverse stock split within one year of the special meeting and to determine the exact ratio.

Management Comments

• The Board recommends that stockholders vote FOR the granting to our Board of Directors authority to effect a reverse stock split.
• Our Board believes that the proposed reverse stock split is a potentially effective means for us to maintain compliance with the listing rules of NASDAQ.
• Our Board believes that we will need to raise additional capital in the ordinary course of business.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from exchanges due to low stock prices. This action is often taken to regain compliance with minimum price requirements and attract institutional investors. The company's situation is not unique, as many small-cap companies face similar challenges in maintaining their listing status.

Comparison to Industry Standards

• Many small-cap biotech companies facing similar stock price challenges have used reverse stock splits to maintain exchange listings, such as Cassava Sciences (SAVA) which has performed multiple reverse stock splits.
• The range of 1-for-2 to 1-for-50 is a typical range for reverse stock splits, with the exact ratio determined by the board based on market conditions.
• The decision to provide cash payments for fractional shares is a standard practice to avoid the complexities of issuing fractional shares.
• The company's previous reverse stock split in June 2024, which did not result in a sustained price increase, highlights the risk that this action may not be a long-term solution.

Stakeholder Impact

• Shareholders will be impacted by the reverse stock split, which will reduce the number of shares they own but may increase the per-share price.
• Shareholders will receive cash payments for fractional shares resulting from the split.
• Employees may be affected by the potential delisting and the company's financial situation.
• The company's ability to raise capital and engage in business development opportunities could be affected by its listing status.

Next Steps

• Stockholders will vote on the reverse stock split proposal at the Special Meeting on November 26, 2024.
• The company will attend a hearing with the NASDAQ Hearings Panel on November 5, 2024.
• If approved, the board will determine the exact reverse stock split ratio and implement it within one year of the special meeting.
• Stockholders will receive instructions on how to exchange their shares after the reverse stock split is implemented.

Key Dates

Keywords

reverse stock split, NASDAQ, delisting, common stock, stock price, fractional shares, cash payment, listing requirements, stockholders, capital market